Loading clinical trials...
Loading clinical trials...
Role of Circulating Tumor DNA (ctDNA) in Genetic Profiling and Clinical Outcomes for Advanced Biliary Tract Cancer (BTC) Patients - Prospective, Observational, Epidemiology Study
Conditions
Interventions
Blood Sampling for ctDNA Analysis
Locations
1
South Korea
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
Start Date
September 1, 2025
Primary Completion Date
August 31, 2027
Completion Date
August 31, 2027
Last Updated
March 18, 2026
NCT06282575
NCT05489211
NCT04900818
NCT07146646
NCT07398339
NCT06428409
Lead Sponsor
CHA University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions